fbpx
Back to Course

PACU Literature Review #21. Safety and Tolerability of 23.4% Hypertonic Saline Administered Over 2 to 5 Minutes for the Treatment of Cerebral Herniation and Intracranial Pressure Elevation

0% Complete
0/0 Steps
O’Brien SK, Koehl JL, Demers LB, Hayes BD, Barra ME. Safety and Tolerability of 23.4% Hypertonic Saline Administered Over 2 to 5 Minutes for the Treatment of Cerebral Herniation and Intracranial Pressure Elevation. Neurocrit Care. Published online September 28, 2022.
 
PMID: 36171519

BACKGROUND

  • In patients with acute brain injury, sustained intracranial hypertension is considered a medical emergency that requires immediate recognition and treatment to prevent progression of cerebral ischemia, brain herniation, and death. Recommended treatment is hyperosmolar therapy with mannitol or hypertonic saline. 23.4% saline is an effective treatment, but historically requires administration via IV infusion.

STUDY OBJECTIVE

  • Prospectively evaluate the safety of administration of 23.4% NaCl as rapid IV push over 2-5 mins

STUDY DESIGN

  • Single-center prospective, observational analysis

Study Intervention & Comparison

  • Documented administration of 23.4% NaCl over 2-5 mins

Results

  • Primary Safety Outcome
    • Composite incidence of hypotension, bradycardia, and infusion site reaction within 60 mins
    • Reported in 31% of unique patients following 15% of administrations
      • All instances of fall in SBP by at least 20mmHg associated with potential alternative or exacerbating factors
      • All instances of SBP <90mmHg were in patients already on vasopressor support
      • One instance of infusion site reaction (pain)
  • Secondary Safety Outcome
    • Comparison of highest and lowest SBP values and lowest heart rate documented within 60 mins
      • No significant changes observed

Summary

  • IV push administration of 23.4% NaCl over 2-5 minutes may be considered a safe, alternative method of administration.

Additional Readings

  • Faiver L, Hensler D, Rush SC, Kashlan O, Williamson CA, Rajajee V. Safety and efficacy of 23.4% sodium chloride administered via peripheral venous access for the treatment of cerebral herniation and intracranial pressure elevation. Neurocrit Care. 2021;35(3):845–52
  • Rockswold GL, Solid CA, Paredes-Andrade E, Rockswold SB, Jancik JT, Quickel RR. Hypertonic saline and its effect on intracranial pressure, cerebral perfusion pressure, and brain tissue oxygen. Neurosurgery. 2009;65(6):1035–41.
  • Ware ML, Nemani VM, Meeker M, Lee C, Morabito DJ, Manley GT. Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study. Neurosurgery. 2005;57(4):727–36